Zobrazeno 1 - 10
of 618
pro vyhledávání: '"C. Charnsangavej"'
Autor:
Eric P. Tamm, Jason B. Fleming, Aparna Balachandran, James C. Yao, C. Charnsangavej, Priya Bhosale, Matthew H.G. Katz
Publikováno v:
AJR. American journal of roentgenology. 199(3)
We sought to determine the incidence of venous tumor thrombus in nonfunctioning pancreatic neuroendocrine tumors.We reviewed CT images of patients with a diagnosis of nonfunctional pancreatic neuroendocrine tumors over a 4-year period. For patients w
Publikováno v:
Acta Radiologica. 33:351-355
Autor:
Niramol Savaraj, Y. Y. Lee, N. Papadopoulos, Sidney Wallace, C. Charnsangavej, C. Plager, Robert S. Benjamin, Lynn G. Feun
Publikováno v:
American Journal of Clinical Oncology. 13:448-451
Twenty-three patients with malignant melanoma metastatic to the central nervous system (CNS) were treated with intracarotid cisplatin-based chemotherapy. Twenty-two had failed prior cranial radiation therapy (one patient refused radiation therapy) an
Autor:
C, Charnsangavej
Publikováno v:
Radiologic Clinics of North America. 28:865-877
Lymphomatous involvement of the genitourinary tract is extremely rare when it presents as primary extranodal disease. It is more common in the advanced stage of disseminated disease. Computed tomography is the best diagnostic modality to detect the i
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 42(10)
Significant liver uptake often limits the clinical application of radiolabeled antibodies in radioimmunodetection. The purpose of this study was to evaluate the gamma-imaging properties of an antiepidermal growth factor receptor (EGFR) antibody, C225
Autor:
E, Tamm, C, Charnsangavej
Publikováno v:
Cancer journal (Sudbury, Mass.). 7(4)
Because of its late clinical presentation, pancreatic cancer remains the fourth most common cause of cancer death. Surgery is the only option for cure, and advancements in surgical technique and neoadjuvant therapy have the potential to increase the
Autor:
R A, Wolff, D B, Evans, D M, Gravel, R, Lenzi, P W, Pisters, J E, Lee, N A, Janjan, C, Charnsangavej, J L, Abbruzzese
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 7(8)
Gemcitabine has modest activity in the treatment of advanced pancreatic cancer and is a potent radiosensitizer. We conducted a Phase I trial to determine the maximum tolerated dose of weekly gemcitabine delivered concurrently with radiation therapy f
Publikováno v:
Oncology (Williston Park, N.Y.). 14(12 Suppl 14)
Chemotherapy for advanced gastric and gastroesophageal junction carcinomas remains suboptimal. Both irinotecan (Camptosar) and cisplatin (Platinol) are active against this group of malignancies. This article focuses on the results of an ongoing phase
Autor:
C, Li, S, Ke, Q P, Wu, W, Tansey, N, Hunter, L M, Buchmiller, L, Milas, C, Charnsangavej, S, Wallace
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 6(7)
The poly(L-glutamic acid)-paclitaxel (PG-TXL) conjugate has been shown to exhibit significantly greater antitumor activity than conventionally formulated paclitaxel (TXL) against solid tumors (Li et al., Cancer Res., 58: 2404-2409, 1998). Here we rep
Publikováno v:
Current problems in diagnostic radiology. 29(3)